# Does the Energy Restriction Intermittent Fasting Diet Alleviate Metabolic Syndrome Biomarkers?

> **NCT04502329** · NA · COMPLETED · sponsor: **Istanbul Medipol University Hospital** · enrollment: 65 (actual)

## Conditions studied

- Metabolic Syndrome

## Interventions

- **OTHER:** Diet

## Key facts

- **NCT ID:** NCT04502329
- **Lead sponsor:** Istanbul Medipol University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-30
- **Primary completion:** 2020-03-10
- **Final completion:** 2020-06-10
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2020-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04502329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04502329, "Does the Energy Restriction Intermittent Fasting Diet Alleviate Metabolic Syndrome Biomarkers?". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04502329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*